Pharma Journalist -

ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for cancer and other genetically-defined diseases, and Asieris Pharmaceuticals, a…
Read More...

West Pharmaceutical Services, Inc. announces the expansion of its landmark collaboration with Corning Incorporated (NYSE: GLW), that now includes the exclusive distribution rights for…
Read More...

Syneos Health announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence (AI) and Natural Language Processing…
Read More...

Kiora Pharmaceuticals, Inc. announced it has received investigational new drug application approval for a Phase 2 study of KIO-101 for the treatment of the Ocular Presentation of…
Read More...

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos in combination with a rituximab or…
Read More...

Forxiga (dapagliflozin) has been approved in the European Union to extend the indication for heart failure (HF) with reduced ejection fraction (HFrEF) to cover patients across the full…
Read More...

Aldeyra Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for topical ocular reproxalap, a first-in-class…
Read More...

Genenta Science, a clinical-stage biotechnology company engaged in the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, has entered into a development…
Read More...

Healthcare continues to face crippling staff shortages, while communities are left underserved, and the national mental health crisis persists. Providers are battling to meet…
Read More...

Biogen Inc. and Sage Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of…
Read More...